4//SEC Filing
CLEVELAND BIOLABS INC 4
Accession 0001209191-15-039691
CIK 0001318641operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 9:30 PM ET
Size
5.2 KB
Accession
0001209191-15-039691
Insider Transaction Report
Form 4
Miller Langdon L
President & CMO
Transactions
- Award
Stock Option (right to buy)
2015-05-04+10,000→ 10,000 totalExercise: $3.00From: 2016-05-04Exp: 2025-05-04→ Common Stock (10,000 underlying)
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001318641
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 9:30 PM ET
- Size
- 5.2 KB